Premium
BCR‐ABL1 tyrosine kinase inhibitor‐associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature
Author(s) -
Patel Shital,
Nayernama Afrouz,
Jones Steven Christopher,
Claro Romeo Angelo,
Waldron Peter E.
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25997
Subject(s) - adverse event reporting system , adverse effect , medicine , pharmacology